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OBJECTIVE: The effects of natural adjuvants on lung inflammation and tracheal responsiveness were examined
in sensitized guinea pigs.
METHODS: The responses of guinea pig tracheal chains and the serum levels of interleukin-4 and interferon-
gamma were examined in control pigs and three other groups of guinea pigs: the sensitized group and two
other sensitized groups treated with either adjuvant G2 or adjuvant G2F (n=7 for each group). Sensitization of
the animals was achieved by injection and inhalation of ovalbumin.
RESULTS: The results showed that sensitized animals had increased tracheal responsiveness and increased serum
levels of interleukin-4 and interferon-gamma compared to controls (p,0.05 to p,0.001). Treatments with
either G2 or G2F prevented the increase in tracheal responsiveness and serum interleukin-4 (p,0.01 to
p,0.001). However, the serum levels of interferon-gamma and the interleukin-4-to-interferon-gamma ratio
was increased in the treated groups (p,0.001 for all cases).
CONCLUSIONS: These results indicate important preventive effects of two natural adjuvants, particularly G2, on
the changes in tracheal responsiveness, serum cytokines and the interleukin-4-to-interferon-gamma ratio (T
helper 1/T helper 2 balance) in sensitized guinea pigs.
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& INTRODUCTION
The hallmark of asthma is airway hyper-responsiveness
(AHR) to many stimuli (1), and it is believed to be due to
airway inflammation (2). In addition, the T helper 2 system
is activated in asthma, and its mediators cause many
features of asthma, such as airway inflammation, mucus
secretion and airway hyper-responsiveness (3). The T helper
1 system has been shown to inhibit T helper 2 responses.
Therefore, one goal of asthma therapy should be focused on
increasing the activity of the T helper 1 system by means of
natural immunomodulators (4).
G2 is buffalo spleen extract. Theories of alternative
medicine have suggested that the consumption of spleen
extract supports the immune system (5,6). The effects of calf
spleen extract, including inhibiting lymphocyte proliferation
in a tissue-specific, species-nonspecific, nontoxic and rever-
sible manner (7) and stimulating polymorphonuclear leuko-
cyte activities (8), have been confirmed. Phosphodiesterase
enzymes, nucleotidyltransferase activity (9) and a factor that
inhibits DNA synthesis found in lymphocytes from the
lymph nodes and thymus of guinea pigs and rats have also
been isolated from the calf spleen (10).
G2F adjuvant is concentrated G2 adjuvant in sesame seed
oil. Sesame seed has been used to make oil since ancient
times. The earliest sesame findings date back to 3000 years
BC in the history of the Middle East. Ancient athletes used it
to enhance their power and physical fitness. The pure oil of
sesame seeds and its components have been used as
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adjuvants for various purposes; this oil has been reported to
increase vaccine potency (11), enhance cellular immunity as
an adjuvant (12) and improve natural killer cell activity (13),
but it does not affect antibody production (14). Moreover,
sesame oil has antioxidant activity, inhibits lipid peroxida-
tion and can be used as a drug delivery system (15,16).
The effect of the G2 adjuvant on breast cancer (17) and its
stimulatory effects on Th1 cells have also been observed
(18). The therapeutic effects of the G2 adjuvant on different
illnesses such as allergies and asthma, have also been
suggested (19). Therefore, the therapeutic effects of this
adjuvant on different disorders and its mechanisms of
action should be studied.
The safety of this adjuvant was demonstrated by daily
injection of eight different doses of G2, including 1, 2.5, 5, 10,
20, 40, 80 and 160 mg, in mice (i.p.) for 18 weeks (n = 20 for
each dose). Only a few deaths occurred, mostly among the
animals receiving high doses of adjuvant (18 of the total of
160 animals). There was no relationship between the
number of dead animals and the administered doses.
In our earlier study, the separate and combined pre-
ventive effects of G2 and PC (another adjuvant of bacterial
origin) on sensitized guinea pigs were demonstrated (20).
Therefore, in the present study, we examined the effects of
the G2 and G2F adjuvants on the tracheal responsiveness
and blood cytokine levels of sensitized guinea pigs.
& MATERIALS AND METHODS
Animal sensitization and different groups
Guinea pigs were sensitized to ovalbumin (OA) (Sigma
Chemical Ltd UK) by injecting 100 mg i.p. and 100 mg s.c.
on day 1 and a further 10 mg i.p. on day 8. From day 14, the
sensitized animals were exposed to an aerosol of 4% OA for
18¡1 days for 4 min daily (21-23). The aerosol was admini-
stered in a closed chamber (dimensions: 30620620 cm).
Control animals were treated similarly, but saline was used
instead of OA solution. The study was approved by the
ethical committee of the Mashhad University of Medical
Sciences.
A total of 28 adult Dunkin-Hartley guinea pigs (550 to
700 g, purchased from Razi Animal Institute, Mashhad,
Iran) and were divided into four groups of 7 animals each,
with a similar male-to-female ratio. All of the female
animals were studied on the same days of their estrous
cycles. The four groups were created as follows: 1) C: non-
sensitized, control group; 2) S: animals sensitized to
ovalbumin (an animal model of asthma) that received
normal saline, 0.5 ml i.p. twice a week for 4 weeks; 3)
S+G2: sensitized animals treated with adjuvant G2, 0.4 ml
i.p. twice per week for 4 weeks; and 4) S+G2F: sensitized
animals treated with adjuvant G2F, 0.1 ml i.p. twice per
week for 4 weeks. The doses of adjuvants used were
according to previous studies (19,20).
The animals were group-housed in individual cages in
climate-controlled animal quarters and were given water
and food ad libitum, while a 12-h on/12-h off light cycle was
maintained.
Studied adjuvants
The G2 adjuvant is a buffalo spleen lipid that is registered
as a patent in the Iranian Patent Office as follows: Immune
System Activator Vaccine (Innovation Register No.: 36679,
October 28, 2006). Briefly, spleens were crushed and diluted
in alcohol for a few days, before being centrifuged at 8006g
for 30 mins. The supernatant was dried to obtain a
concentration of 20 mg/ml. The G2 adjuvant’s components
included different types of lipids, glucose, cholesterol and
triglycerides.
For the G2F preparation, crude sesame seed oil from the
Esfahan state in central Iran was filtered with 0.5-mm filter
paper to remove particles. The oil was then centrifuged at
10000 rpm at room temperature. The supernatant was
filtered with 0.22-mm pure-sized filters under vacuum
filtration. A total of 300 mg/ml G2 was added to the resulting
preparation; the mixture was called G2F and divided into
5-ml aliquots in glass vials under sterile conditions.
Tissue preparations
The guinea pigs were sacrificed by cervical dislocation
and the trachea was removed. Each trachea was cut into 10
rings (each containing 2-3 cartilaginous rings) and the rings
were cut open opposite the trachealis muscle and were
sutured together to form a tracheal chain (24,25).
The tissue was suspended in a 10-ml organ bath (organ
bath 61300, BioScience Palmer-Washington, Sheerness,
Kent, U.K.) containing Krebs-Henseliet solution with the
following composition (mM): NaCl 120, NaHCO3 25, MgSO4
0.5, KH2PO4 1.2, KCl 4.72, CaCl2 2.5 and dextrose 11. The
Krebs solution was maintained at 37 C˚ and was aerated
with 95% O2 and 5% CO2. The tissue was suspended under
isotonic tension of 1 g and was allowed to equilibrate for at
least 1 h, while it was washed with Krebs solution every
15 min.
Assessment of the tracheal response to
methacholine
A cumulative log concentration-response curve of methacho-
line hydrochloride (Sigma Chemical Ltd., Poole, Dorset, U.K.),
which induced contraction of the tracheal chain, was obtained
in each experiment. Different concentrations of methacholine
were added every 2 min: 0.1, 0.5, 1, 5, 10, 50 mM, 0.1, 0.5, 1 and
5 mM. The contraction elicited by each concentration was
recorded at the end of 2 min and the effects plateaued in all of
the experiments. The percentage of contraction of the tracheal
smooth muscle due to each concentration of methacholine, in
proportion to the maximum contraction obtained by its final
concentration, was plotted against the log concentration of
methacholine to obtain the curve.
The contractility response to 10 mM methacholine, which
is the concentration that caused approximately 60-70% of
maximum response, was also measured as the magnitude
of contraction in milligrams. The effective concentration of
methacholine causing 50% of the maximum response (EC50)
was also determined from each methacholine response
curve.
Measurement of IL-4 and IFN-c in serum
Five milliliters of peripheral blood were obtained imme-
diately after sacrificing the animals and were kept at room
temperature for 1 h. The samples were then centrifuged at
2500 rpm at 4 C˚ for 5 min. The supernatant was collected
and immediately stored at -20 C˚ until the time of analysis.
The serum levels of IL-4 and IFN-c were measured using an
interleukin-4 (IL-4) and interferon-c (IFN-c) ELISAA kit
(Antibodies-online Inc., Atlanta, GA, USA), with a mini-
mum detection limit of 1 pg/ml.
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The data are reported as means ¡ SEM. The ratio of IL-4
to IFN-c was calculated. According to the Kolmogorov-
Smirnov test, these data had a normal distribution. The data
of the four groups of animals were compared using
ANOVA. Significance was accepted at p,0.05.
& RESULTS
Tracheal response to methacholine
The cumulative log concentration response curve
obtained in the sensitized (S) group showed a leftward
shift, compared to the curve for the control group. However,
the curves obtained in the S+G2 and S+G2F groups showed
rightward shifts compared to the S group so that the curve
obtained in the S+G2 and S+G2F groups was also shifted
slightly to the left, compared to the curve of the control
group (Figure 1).
The mean EC50 value in the tracheal chains of the S
animals (0.59¡0.11 mM) was significantly lower than the
EC50 value in the control group (4.10¡0.62 mM, p,0.001)
(Figure 2a). However, the EC50 value in the S+G2
(4.43¡0.88 mM) and S+G2F (4.21¡0.44 mM) groups showed
significant improvement, compared to that in the S group
(p,0.001 for both treated groups, Figure 2a).
Contractility response to methacholine
The mean value of the contractility response to methacho-
line in the tracheal chains of the S animals (217.14¡
14.90 mg) was significantly greater than that in the control
group (109.29¡19.00 mg, p,0.001) (Figure 2b). However,
the maximum contractility response in the S+G2 (88.00
¡8.10 mg) and S+G2F (135.86¡7.16 mg) groups showed
significant improvement, compared to that of the S group;
these values were statistically significant for the S+G2 and
S+G2F groups (p,0.001 and p,0.01 for S+G2 and S+G2F,
respectively, Figure 2b).
Levels of IL-4 and IFN-c in serum
There was a significant increase in the levels of IL-4 and
IFN-c in the serum of the S animals, compared to those in
the controls (p,0.05 for both cases). Both treatment groups
were associated with a small but significant reduction in IL-
4 (p,0.01 for both cases) and a substantial, highly significant
increase in IFN-c (p,0.001 for both cases, Figure 3a and b).
The ratio of IFN-c to IL-4 did not change in the sensitized
group, but it was significantly increased in both treated
groups (p,0.001 for both cases, Figure 3c).
Differences in the different parameters between
the two groups of animals treated with the
adjuvants
There were no significant differences in the EC50 value,
contractility response to methacholine, serum levels of IL-4
and IFN-c or the IL-4-to-IFN-c ratio between the S+G2F and
S+G2 groups (Figures 1-3).
& DISCUSSION
Increased tracheal response to methacholine and the
maximum tracheal response to methacholine in the
sensitized guinea pigs compared to those of the control
animals were seen in the present study. Serum interleukins
(INF-c and IL-4) were also significantly increased in the
sensitized animals, compared to the control group; these
results were very similar to the results of our previous
studies, using a similar method of sensitization (26-28).
Increased tracheal responsiveness to methacholine and
serum cytokine levels constitute further confirmation of
sensitization (28,29).
Treatment of the S animals with G2 or G2F adjuvants
prevented the increase in tracheal responsiveness to
methacholine and serum levels of IL-4, but it caused further
increases in serum INF-c levels and increased the INF-c-to-
IL-4 ratio. There were no significant differences in the EC50
value, contractility response to methacholine, serum levels
of IL-4 and IFN-c or the IL-4-to-IFN-c ratio between the
S+G2F and S+G2 groups.
The preventive effects of the studied adjuvants on
increased tracheal responsiveness, IL-4 and IFN-c levels
and the IL-4-to-IFN-c ratio changes in sensitized guinea
pigs indicated that the adjuvants had anti-inflammatory
properties.
Figure 1 - Cumulative log concentration-response curves of
methacholine-induced contraction of the isolated trachea in the
control (C), sensitized (S), S treated with adjuvant G2 (S+G2) and
S treated with adjuvant G2F (S+G2F) guinea pigs (for each group,
n=7).
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The possible mechanism of action of these adjuvants is
related to the regulation of the Th1 and Th2 balance. Th2
cells increase the activity of macrophages and regulate the
pro-inflammatory response through the production of IL-4
and IL-10 but not of IFN-c or IL-2, whereas Th1 cells inhibit
the activity of macrophages directly or indirectly by
inhibiting Th2 activity and thus regulating the anti-
inflammatory response through interleukin 2 (IL-2) and
interferon-c (IFN-c) (30). The preventive effects of the
studied adjuvant on IL-4, IFN-c and the IFN-c/IL-4 ratio
observed in the present study suggested the effect of
adjuvants on the Th1/Th2 balance. The stimulatory effects
of these adjuvants on Th1 cells (18) and the effects of calf
spleen extract on the immune system (7-10) were demon-
strated in previous studies that supported the findings of
the present study.
Oxidative stress plays an important role in asthmatic
airway inflammation and might be a useful therapy for
bronchial asthma (31,32). Therefore, the antioxidant proper-
ties of the adjuvants might constitute another mechanism
for their effects. In fact, the preventive effects of antioxidants
in patients with asthma have been controversial (33-35). The
effects of vitamin C and the extract of Nigella sativa, both of
which have anti-oxidant properties against the increased
tracheal responsiveness of sensitized guinea pigs using a
similar method of sensitization, have been shown (36,37).
Therefore, the antioxidant effects of these adjuvants should
be examined in future studies. The preventive effects of the
G2 and G2F adjuvants on lung inflammation (total and
differential WBC counts) in sensitized guinea pigs were also
demonstrated (38).
Sesame seed oil increases cellular immunity (11) and
natural killer cell activity (12) and it has antioxidant activity
(15,16). Therefore, the protective effects of extract of sesame
seed could be due to its effects on immunity mechanisms or
its antioxidant properties. Further studies are needed to
Figure 2 - Individual values and means ¡ SEMs (large symbols
with bars) of the tracheal response to methacholine (EC50) (a)
and maximum contractility (b) in the four groups of guinea pigs
(n =7): control (C), sensitized (S), S treated with adjuvant G2
(S+G2) and S treated with adjuvant G2F (S+G2F). Significant
differences between the control and sensitized groups: +++;
p,0.001. Significant differences between the G2 and G2F groups
vs the S group: **; p,0.01, ***; p,0.001. There was no
significant difference in the EC50 or maximum contractility
between the S+G2 and S+G2F groups.
Figure 3 - Serum levels of IFN-c (a), IL-4 (b) and IFN-c-to-IL-4 ratio
(c) in control, sensitized (S), S treated with adjuvant G2 (S+G2)
and S treated with adjuvant G2F (S+G2F) guinea pigs (for each
group, n=7). Significant differences between the control and
sensitized group: +; p,0.05. Significant differences between the
S+G2 and S+G2F groups vs the S group: **; p,0.01, ***; p,0.001.
There was no significant difference between the S+G2 and S+G2F
groups.
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determine its effects on the regulation of Th1/Th2 balance
and to measure directly the antioxidant properties of the
adjuvants used in the current study.
The administered dose of the G2F form of the adjuvant
was higher than that of the G2 adjuvant (30 mg vs 8 mg). In
addition, the extract of sesame seed present in the G2F
adjuvant demonstrated cellular immunity and antioxidant
properties. However, the effects of the G2 adjuvant in the
prevention of increased tracheal responsiveness (reduction
of EC50), contractility and eosinophil and neutrophil
infiltration tended to be greater (although non-significantly)
than those of G2F, and the G2 adjuvant’s effects on total
WBC and basophil counts were significantly greater than
those of the G2F adjuvant. The mechanism of these
discrepancies is currently unclear. One possible mechanism
could be a non-specific adverse effect of a higher concentra-
tion of the adjuvant. However, the mechanism(s) of this
discrepancy and possible adverse effects should be exam-
ined in further studies.
The results of the present study might suggest a
preventive effect of the studied adjuvant on asthma by
the regulation of the Th1/Th2 balance and/or anti-
inflammatory effects. However, the other possible factors
that influence these effects, including the dose of adminis-
tration in asthmatic patients, the duration of effective
treatment and tolerance by the patients, should be examined
in further studies. In addition, the effects of different doses
of the G2 and G2F adjuvants should be studied in sensitized
animals before beginning human studies, to determine the
optimal effective doses.
Regarding possible lymphocyte migration into different
lung compartments from the spleen and its influence on
lung immune response, it has been well documented that
lymphocyte migration into the bronchoalveolar space after
local challenge seems to be triggered by the inflamed lung
and not by migrating cells from the spleen. Furthermore, the
spleen is not the main source of lymphocytes in pulmonary
immune reactions or cellular immune reactions (39).
Increases in total WBC and in eosinophil, neutrophil and
basophil counts in lung lavage of sensitized guinea pigs
were also shown in our previous study (38). The effects of
natural adjuvants on IL-4 and IFN-c in lung lavage of a
mouse model of experimental asthma also showed results
that were very similar to those of the present study
regarding both the quantity and effects of adjuvants (40),
supporting the results of the present study. In addition, the
effects of adjuvants on tracheal responsiveness shown in the
present study, as well as their effects on total and
differential WBC (38) and lung pathological changes (40),
in sensitized animals confirmed their effects on lung
inflammation in asthma.
In addition, the results of our recent study showed that, in
cultured splenic lymphocytes from the control group, the
levels of IFN-c and IL-4 and the IFN-c-to-IL-4 ratios
were 3.91¡1.23, 2.82¡0.92 and 1.37¡1.07, respectively. In
splenic lymphocytes that were stimulated with PHA, these
values were 7.54¡2.15, 8.21¡1.28 and 0.83¡0.47, respec-
tively, and in stimulated lymphocytes that were treated
with the extract of Nigella sativa, these values were
13.82¡2.31, 4.06¡0.83 and 3.29¡0.86, respectively (unpub-
lished data). In fact, the results with the extract of Nigella
sativa (41) were very similar to those in the present study
with the natural adjuvants. Therefore, these results also
support the effects of these adjuvants on the serum levels of
IFNc and IL-4 and the IFN-c-to-IL-4 ratio in the sensitized
guinea pigs.
In conclusion, the results of the present study indicated
the preventive effects of the G2 and G2F natural adjuvants
on tracheal responsiveness, changes in serum cytokine
levels and the IFN-c/IL-4 ratio (Th1/Th2 balance) in
sensitized guinea pigs.
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